Despite the bear market rally, the market is facing serious risks due to rising recession risk and increasing geopolitical tensions. Here are 3 defensive picks to help investors outperform in this tricky environment: Lockheed Martin (LMT), Vertex Pharmaceuticals (VRTX), and Elevance Health (ELVH).

The cybersecurity industry has gained massive attention with the rapid digitalization since the onset of the COVID-19 pandemic. While the tech sell-off on interest rate concerns has led to cybersecurity stocks losing momentum lately, Wall Street analysts see a decent upside for Fortinet (FTNT) in the near term. So, is…

The stock market has had a difficult first half of the year. While the benchmark indexes have witnessed a decent recovery since July, many analysts believe the markets will tumble further on economic and geopolitical concerns. Amid this backdrop, it could be wise to add defensive stocks to your portfolio.…

Comcast Corporation (CMCSA) has gained solid market standing through various strategic collaborations and operational advancements. In addition, the company’s solid dividend growth track record exhibits the management’s growing confidence in CMCSA’s prospects. So, we think the stock could be a great buy now. Keep reading.

Leading healthcare company CVS Health (CVS) reported strong second-quarter results and raised its fiscal 2022 full-year EPS and cash from operations guidance. Moreover, the company expects considerable growth across all its business segments, driven by its differentiated business model. Given the competitive advantages of its products and services, CVS continues…

Gilead Sciences (GILD), a biopharmaceutical company, reported strong demand across its HIV portfolio and raised its full-year guidance. Given the company’s robust profitability and discounted valuation, we think it could be wise to buy the stock now. Read on….